Co-diagnostics Inc. sell Biotechhunter
Start price
28.08.20
/
50%
€9.25
Target price
28.08.20
-
Performance (%)
-1.08%
End price
28.08.20
€9.15
Summary
This prediction ended on 28.08.20 with a price of €9.15. With a performance of -1.08%, the SELL prediction for Co-diagnostics Inc. by Biotechhunter was down slightly. Biotechhunter has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Co-diagnostics Inc. | - | - | - | - |
iShares Core DAX® | 2.147% | 2.681% | 17.410% | 16.694% |
iShares Nasdaq 100 | -0.578% | -0.816% | 24.107% | 34.957% |
iShares Nikkei 225® | 0.635% | 3.079% | 16.921% | 11.023% |
iShares S&P 500 | 0.746% | 0.171% | 23.802% | 37.315% |
According to Biotechhunter what are the pros and cons of Co-diagnostics Inc. for the foreseeable future?
Pros
Cons
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
overvalued
Very low/no dividend yield expected
very negative Cash Flow expected
Junk rating
Very little Investments for future growth
High risks in the balance sheet
High risks for its business
Nicheplayer
Outdated or very high risk business model
Comments by Biotechhunter for this prediction
In the thread Co-diagnostics Inc. diskutieren
Sell Co-diagnostics Inc.
In the thread Trading Co-diagnostics Inc.
Sell beendet
Stopped prediction by Biotechhunter for Co-diagnostics Inc.
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€7.10
05.09.20
05.09.20
-
04.11.21
04.11.21
-12.39%
15.07.21
15.07.21
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€7.00
04.09.20
04.09.20
-
05.09.20
05.09.20
1.43%
05.09.20
05.09.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€7.75
04.09.20
04.09.20
-
04.09.20
04.09.20
-9.68%
04.09.20
04.09.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€7.75
03.09.20
03.09.20
-
04.09.20
04.09.20
0.00%
04.09.20
04.09.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€8.20
02.09.20
02.09.20
-
03.09.20
03.09.20
-5.49%
03.09.20
03.09.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€8.85
02.09.20
02.09.20
-
02.09.20
02.09.20
-7.34%
02.09.20
02.09.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€8.85
01.09.20
01.09.20
-
02.09.20
02.09.20
0.00%
02.09.20
02.09.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€9.10
31.08.20
31.08.20
-
01.09.20
01.09.20
-2.75%
01.09.20
01.09.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€9.15
28.08.20
28.08.20
-
31.08.20
31.08.20
-0.55%
31.08.20
31.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€9.65
27.08.20
27.08.20
-
28.08.20
28.08.20
-4.15%
28.08.20
28.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€11.90
20.08.20
20.08.20
-
27.08.20
27.08.20
-18.91%
27.08.20
27.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€12.30
19.08.20
19.08.20
-
20.08.20
20.08.20
-3.25%
20.08.20
20.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€12.90
18.08.20
18.08.20
-
19.08.20
19.08.20
-4.65%
19.08.20
19.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€13.30
17.08.20
17.08.20
-
18.08.20
18.08.20
-3.01%
18.08.20
18.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€14.00
17.08.20
17.08.20
-
17.08.20
17.08.20
-5.00%
17.08.20
17.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€14.70
17.08.20
17.08.20
-
17.08.20
17.08.20
-4.76%
17.08.20
17.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€14.80
13.08.20
13.08.20
-
17.08.20
17.08.20
-0.68%
17.08.20
17.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€18.20
13.08.20
13.08.20
-
13.08.20
13.08.20
-18.68%
13.08.20
13.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€18.40
13.08.20
13.08.20
-
13.08.20
13.08.20
-1.09%
13.08.20
13.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€17.10
12.08.20
12.08.20
-
13.08.20
13.08.20
7.60%
13.08.20
13.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€20.60
11.08.20
11.08.20
-
12.08.20
12.08.20
-16.99%
12.08.20
12.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€20.80
01.08.20
01.08.20
-
11.08.20
11.08.20
-0.96%
11.08.20
11.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€20.20
31.07.20
31.07.20
-
01.08.20
01.08.20
2.97%
01.08.20
01.08.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€19.70
24.07.20
24.07.20
-
31.07.20
31.07.20
2.54%
31.07.20
31.07.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
Co-diagnostics Inc.
Start price
Target price
Perf. (%)
€18.80
21.07.20
21.07.20
-
24.07.20
24.07.20
4.79%
24.07.20
24.07.20
Risky Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group